HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Direct binding of influenza peptides to class I HLA molecules.

Abstract
Activation of T lymphocytes requires the intracellular fragmentation of foreign antigens and their presentation by class I or class II major histocompatibility complex (MHC) glycoproteins. The direct binding of peptides to class II molecules has been demonstrated using equilibrium dialysis, gel filtration and fluorescence energy transfer at planar membranes, and its specificity compared to that of T-cell activation. In contrast, direct binding of peptides to class I molecules has been difficult to detect; although peptide sensitization experiments and the crystallographic structure of HLA-A2 (ref. 9) persuasively argue for its occurrence and importance. Here we describe a gel filtration assay from which we derive direct evidence for selective binding of an influenza matrix peptide to HLA-A2 and for binding of an influenza nucleoprotein peptide to HLA-B37. These two peptides have previously been shown to act respectively as targets for certain HLA-A2 or HLA-B37 restricted influenza-specific cytotoxic T lymphocytes (CTL). In addition we demonstrate binding to some, but not all, HLA allospecificities that cannot present these peptides to CTL. We estimate that less than 0.3% of the HLA molecules present in any given purified preparation were able to bind the added peptides.
AuthorsB P Chen, P Parham
JournalNature (Nature) Vol. 337 Issue 6209 Pg. 743-5 (Feb 23 1989) ISSN: 0028-0836 [Print] England
PMID2918908 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HLA-A Antigens
  • HLA-B Antigens
  • Histocompatibility Antigens Class I
  • M-protein, influenza virus
  • Viral Matrix Proteins
Topics
  • Amino Acid Sequence
  • Chromatography, High Pressure Liquid
  • Crystallography
  • HLA-A Antigens (metabolism)
  • HLA-B Antigens (metabolism)
  • Histocompatibility Antigens Class I (metabolism)
  • Humans
  • Viral Matrix Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: